Sulfamide → HCID 89618812, compound
Reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C@H:9]1[CH2:13][CH2:12][CH2:11][N:10]1[C:14]1[CH:19]=[CH:18][N:17]2[N:20]=[CH:21][C:22]([C:23]([NH:25][C@H:26]3[CH2:30][CH2:29][NH:28][CH2:27]3)=[O:24])=[C:16]2[CH:15]=1.[S:31](N)([NH2:34])(=[O:33])=[O:32]>>[F:1][C:2]1[CH:7]=[CH:6][C:5]([F:8])=[CH:4][C:3]=1[C@H:9]1[CH2:13][CH2:12][CH2:11][N:10]1[C:14]1[CH:19]=[CH:18][N:17]2[N:20]=[CH:21][C:22]([C:23]([NH:25][C@H:26]3[CH2:30][CH2:29][N:28]([S:31](=[O:33])(=[O:32])[NH2:34])[CH2:27]3)=[O:24])=[C:16]2[CH:15]=1Participants
3
Procedure
The title compound was prepared by the method substantially similar to that mentioned in Example-98, using 5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-N-((S)-pyrrolidin-3-yl)pyrazolo[1,5-a]pyridine-3-carboxamide (Example-82) and Sulfamide to afford the crude, which was purified by Preparative HPLC [Column: 21.2×250×7 um, Zorbax, XDB,C-18(#22), Mobile phase-A: 10 mmol.NH4OAc in water, B: ACN, Gradient (Time/% B): 0/30, 2/30, 8/90 and Flow rate: 20 mL/min] to afford 26 mg of the title compound.
Workup
- customThe title compound was prepared by the method substantially similar to
- customto afford the crude, which
- customwas purified by Preparative HPLC [Column: 21.2×250×7 um, Zorbax, XDB,C-18(#22), Mobile phase-A: 10 mmol.NH4OAc in water, B: ACN, Gradient (Time/% B): 0/30, 2/30, 8/90 and Flow rate: 20 mL/min]
Sources & evidence
- ORD record
- ord-f773d24c15e8400bbff1c8b98ed80d8e
- Source dataset
- uspto-grants-2016_03
- Patent number
- US09289419B2
Reaction notes
Loading…